Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neuroblastoma 44Ganglioneuroblastoma 5Medulloblastoma 4Lung Neoplasms 4Leukemia, Myelomonocytic, Juvenile 4Glioblastoma 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Kidney Neoplasms 3Head and Neck Neoplasms 3Gliosarcoma 3Glioma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Rhabdoid Tumor 2Recurrence 2Prostatic Neoplasms 2Pinealoma 2Oligodendroglioma 2Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Dexamethasone 110Cyclophosphamide 99Melphalan 91Bortezomib 68Peripheral Blood Stem Cell Transplantation 63Lenalidomide 57fludarabine phosphate 55Busulfan 53Filgrastim 50Antilymphocyte Serum 38Tacrolimus 37Thalidomide 36Radiotherapy 36Mycophenolic Acid 32fludarabine 28Cyclosporine 26Methotrexate 25Etoposide 22Calcium Dobesilate 22Prednisone 21Whole-Body Irradiation 20Methylprednisolone 20sargramostim 19pomalidomide 19Granulocyte Colony-Stimulating Factor 18carfilzomib 16daratumumab 15Cord Blood Stem Cell Transplantation 14Carmustine 14Rituximab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Plasma Cell × Isotretinoin × Clear all
NCT00021359 2013-07-10

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

Fox Chase Cancer Center

Phase 2 Completed
17 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡